Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer-Reference-Cited by-同舟云学术

Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer

Published:2019-10 Issue:10 Volume:12 Page:1289-1295
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Jiang Zewei,Albanese Joseph,Kesterson Joshua,Warrick Joshua,Karabakhtsian Rouzan,Dadachova Ekaterina,Phaëton Rébécca

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference35 articles.

1. ICO HPV Information Centre. Human Papillomavirus and Related Diseases Report - World.; 2015. doi:23 July 2017

2. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide;Walboomers;J Pathol,1999

3. Natural history and epidemiology of HPV infection and cervical cancer;Castellsague;Gynecol Oncol,2008

4. Molecular biology of cervical cancer and its precursors;Park;Cancer,1995

5. Tumor suppressor or oncogene? A critical role of the human papillomavirus (HPV) E2 protein in cervical cancer progression;Bellanger;Am J Cancer Res,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular aspects of cervical cancer: a pathogenesis update;Frontiers in Oncology;2024-03-19

2. Future directions in cervical cancer treatment;Strategies for Overcoming Chemotherapy Resistance in Cervical Cancer;2024

3. Production of monoclonal antibodies for therapeutic purposes: A review;International Immunopharmacology;2023-07

4. Monoclonal antibodies in cervical malignancy-related HPV;Frontiers in Oncology;2022-10-06

5. E6 and E7 Oncoproteins: Potential Targets of Cervical Cancer;Current Medicinal Chemistry;2021-12-22